Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood

被引:90
作者
Chien, CA
Cheng, JL
Chang, WT
Tien, MH
Tsao, CM
Chang, YH
Chang, HY
Hsieh, JF
Wong, CH
Chen, ST [1 ]
机构
[1] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
[2] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan
[3] Natl Tsing Hua Univ, Inst Life Sci, Hsinchu 300, Taiwan
[4] Ton Yen Gen Hosp, Dept Obstet & Gynecol, Hsinchu 300, Taiwan
[5] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan
关键词
Ganoderma lucidum; Reishi polysaccharides; fluorescent labeled; flow cytometry; umbilical cord blood; natural killer cells; Alamar blue;
D O I
10.1016/j.bmc.2004.08.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In our previous study, a fucose-containing glycoprotein fraction (F3), isolated from the water-soluble extracts of Ganoderma lucidum, was shown to stimulate mice spleen cell proliferation and cytokine expression. We now further investigate the effect of F3 on the immunophenotypic expression in mononuclear cells (MNCs). When human umbilical cord blood (hUCB) MNCs were treated with F3 (10-100 mug/mL) for 7 days, the population of CD14(+)CD26(+) monocyte/macrophage, CD83(+)CD1a(+) dendritic cells, and CD16(+)CD56(+) NK-cells were 2.9, 2.3, and 1.5 times higher than those of the untreated controls (p < 0.05). B-cell population has no significant change. T cell growth was, however, slightly inhibited and CD3 marker expression decreased similar to20%, in the presence of higher concentrations of F3 (100 mug/mL). We also found that F3 is not harmful to human cells in vitro, and after F3 treatment, NK-cell-mediated cytotoxicity was significantly enhanced by 31.7%, (p < 0.01) at effector/target cell ratio (E/T) 20:1, but was not altered at E/T 5:1. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5603 / 5609
页数:7
相关论文
共 26 条
[1]   Role of CD19 signal transduction in B cell biology [J].
Carter, RH ;
Wang, Y ;
Brooks, S .
IMMUNOLOGIC RESEARCH, 2002, 26 (1-3) :45-54
[2]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425
[3]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[4]   Toll receptors, CD14, and macrophage activation and deactivation by LPS [J].
Dobrovolskaia, MA ;
Vogel, SN .
MICROBES AND INFECTION, 2002, 4 (09) :903-914
[5]   Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine [J].
Foley, R ;
Tozer, R ;
Wan, YH .
TRANSFUSION MEDICINE REVIEWS, 2001, 15 (04) :292-304
[6]   Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants [J].
Gritzapis, AD ;
Dimitroulopoulos, D ;
Paraskevas, E ;
Baxevanis, CN ;
Papamichail, M .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (08) :440-448
[7]  
Joshi SS, 1998, INT J ONCOL, V13, P791
[8]  
Lien E J, 1990, Prog Drug Res, V34, P395
[9]   Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest [J].
Lin, SB ;
Li, CH ;
Lee, SS ;
Kan, LS .
LIFE SCIENCES, 2003, 72 (21) :2381-2390
[10]   The structure and function of CD26 in the T-cell immune response [J].
Morimoto, C ;
Schlossman, SF .
IMMUNOLOGICAL REVIEWS, 1998, 161 :55-70